ArticleCancer immunology, immunotherapy : CII2025

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial).

C D'Alterio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.